Cargando…

Kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems

BACKGROUND: Cancer-related fatigue is one of the most prevalent symptoms that patients with cancer experience, but the mechanisms underlying it are unknown. We aimed to quantify and mechanistically evaluate the improvement in fatigue related to administration of the Kampo medicine, Kamikihito. MATER...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamada, Satoshi, Ebisu, Kyoko, Yasuda, Sayaka, Kato, Minoru, Ninomiya, Noriko, Yamasaki, Takeshi, Iguchi, Taro, Nakatani, Tatsuya, Watanabe, Yasuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004623/
https://www.ncbi.nlm.nih.gov/pubmed/29922633
http://dx.doi.org/10.1016/j.prnil.2017.11.002
_version_ 1783332551654375424
author Tamada, Satoshi
Ebisu, Kyoko
Yasuda, Sayaka
Kato, Minoru
Ninomiya, Noriko
Yamasaki, Takeshi
Iguchi, Taro
Nakatani, Tatsuya
Watanabe, Yasuyoshi
author_facet Tamada, Satoshi
Ebisu, Kyoko
Yasuda, Sayaka
Kato, Minoru
Ninomiya, Noriko
Yamasaki, Takeshi
Iguchi, Taro
Nakatani, Tatsuya
Watanabe, Yasuyoshi
author_sort Tamada, Satoshi
collection PubMed
description BACKGROUND: Cancer-related fatigue is one of the most prevalent symptoms that patients with cancer experience, but the mechanisms underlying it are unknown. We aimed to quantify and mechanistically evaluate the improvement in fatigue related to administration of the Kampo medicine, Kamikihito. MATERIALS AND METHODS: Initially, we recruited outpatients with urological diseases and compared fatigue levels of 37 patients with cancer with a control group of 23 volunteers who had recovered completely from cancer or who were being treated for dysuria. Fatigue level was estimated using an autonomic function analyzer. Then, Kamikihito was administered to another 35 patients treated with hormone or antitumor therapy for prostate cancer and metastatic renal cell cancer. Subjective fatigue and other problems of the patients were assessed using the Chalder fatigue scale, the Center for Epidemiologic Studies Depression scale, and the Epworth sleepiness scale. Serum levels of derivatives of reactive oxygen species and biological antioxidant potential were also measured. RESULTS: Patients in the cancer treatment group experienced more fatigue compared with the control patients when evaluated using an autonomic function analyzer. The group of 35 patients who were administered Kamikihito showed improved scores for fatigue, depression, and sleepiness. Autonomic nervous system balance was also improved with Kamikihito administration. The Kamikihito group also had significantly lower reactive oxygen species metabolite levels and significantly higher antioxidant potential. CONCLUSIONS: Fatigue was more serious in patients with cancer than in control patients. Kamikihito rescued this fatigue and improved anxiety and sleepiness. It restored autonomic nervous system balance and antioxidant function.
format Online
Article
Text
id pubmed-6004623
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Asian Pacific Prostate Society
record_format MEDLINE/PubMed
spelling pubmed-60046232018-06-19 Kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems Tamada, Satoshi Ebisu, Kyoko Yasuda, Sayaka Kato, Minoru Ninomiya, Noriko Yamasaki, Takeshi Iguchi, Taro Nakatani, Tatsuya Watanabe, Yasuyoshi Prostate Int Original Article BACKGROUND: Cancer-related fatigue is one of the most prevalent symptoms that patients with cancer experience, but the mechanisms underlying it are unknown. We aimed to quantify and mechanistically evaluate the improvement in fatigue related to administration of the Kampo medicine, Kamikihito. MATERIALS AND METHODS: Initially, we recruited outpatients with urological diseases and compared fatigue levels of 37 patients with cancer with a control group of 23 volunteers who had recovered completely from cancer or who were being treated for dysuria. Fatigue level was estimated using an autonomic function analyzer. Then, Kamikihito was administered to another 35 patients treated with hormone or antitumor therapy for prostate cancer and metastatic renal cell cancer. Subjective fatigue and other problems of the patients were assessed using the Chalder fatigue scale, the Center for Epidemiologic Studies Depression scale, and the Epworth sleepiness scale. Serum levels of derivatives of reactive oxygen species and biological antioxidant potential were also measured. RESULTS: Patients in the cancer treatment group experienced more fatigue compared with the control patients when evaluated using an autonomic function analyzer. The group of 35 patients who were administered Kamikihito showed improved scores for fatigue, depression, and sleepiness. Autonomic nervous system balance was also improved with Kamikihito administration. The Kamikihito group also had significantly lower reactive oxygen species metabolite levels and significantly higher antioxidant potential. CONCLUSIONS: Fatigue was more serious in patients with cancer than in control patients. Kamikihito rescued this fatigue and improved anxiety and sleepiness. It restored autonomic nervous system balance and antioxidant function. Asian Pacific Prostate Society 2018-06 2017-12-06 /pmc/articles/PMC6004623/ /pubmed/29922633 http://dx.doi.org/10.1016/j.prnil.2017.11.002 Text en © 2017 Asian Pacific Prostate Society, Published by Elsevier Korea LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Tamada, Satoshi
Ebisu, Kyoko
Yasuda, Sayaka
Kato, Minoru
Ninomiya, Noriko
Yamasaki, Takeshi
Iguchi, Taro
Nakatani, Tatsuya
Watanabe, Yasuyoshi
Kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems
title Kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems
title_full Kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems
title_fullStr Kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems
title_full_unstemmed Kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems
title_short Kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems
title_sort kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004623/
https://www.ncbi.nlm.nih.gov/pubmed/29922633
http://dx.doi.org/10.1016/j.prnil.2017.11.002
work_keys_str_mv AT tamadasatoshi kamikihitoimprovescancerrelatedfatiguebyrestoringbalancebetweenthesympatheticandparasympatheticnervoussystems
AT ebisukyoko kamikihitoimprovescancerrelatedfatiguebyrestoringbalancebetweenthesympatheticandparasympatheticnervoussystems
AT yasudasayaka kamikihitoimprovescancerrelatedfatiguebyrestoringbalancebetweenthesympatheticandparasympatheticnervoussystems
AT katominoru kamikihitoimprovescancerrelatedfatiguebyrestoringbalancebetweenthesympatheticandparasympatheticnervoussystems
AT ninomiyanoriko kamikihitoimprovescancerrelatedfatiguebyrestoringbalancebetweenthesympatheticandparasympatheticnervoussystems
AT yamasakitakeshi kamikihitoimprovescancerrelatedfatiguebyrestoringbalancebetweenthesympatheticandparasympatheticnervoussystems
AT iguchitaro kamikihitoimprovescancerrelatedfatiguebyrestoringbalancebetweenthesympatheticandparasympatheticnervoussystems
AT nakatanitatsuya kamikihitoimprovescancerrelatedfatiguebyrestoringbalancebetweenthesympatheticandparasympatheticnervoussystems
AT watanabeyasuyoshi kamikihitoimprovescancerrelatedfatiguebyrestoringbalancebetweenthesympatheticandparasympatheticnervoussystems